# Beta-blockers in i-PAH

> **NCT01246037** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 30 (estimated)

## Conditions studied

- Idiopathic Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Bisoprolol

## Key facts

- **NCT ID:** NCT01246037
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246037, "Beta-blockers in i-PAH". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01246037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*